Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase

Clinical Cancer Research

Volumn 11, Issue 3, 2005, Pages 1253-1258

  El Hilali, Nadia ^a   Rubio, Nuria ^a   Blanco, Jerónimo ^a,b  

^a DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^b CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PACLITAXEL;

ARTICLE; BONE; CARCINOGENESIS; GENETIC TRANSFECTION; HISTOGRAM; HUMAN; HUMAN CELL; INOCULATION; LUMINESCENCE; LUNG; LYMPH NODE; MALE; METASTASIS; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; SCROTUM; SEMINAL VESICLE; STATISTICAL ANALYSIS; TARGET ORGAN; TESTIS; TISSUE HOMOGENATE; TUMOR CELL; TUMOR CELL CONTENT; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LUCIFERASES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; PACLITAXEL; PROSTATIC NEOPLASMS; TRANSFECTION; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 12944281687     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. Mechanisms of disease. N Engl J Med 2003;349:366-81.
2. Igawa T, Lin F-F, Lee M-S, Karan D, Batra SK, Lin M-F. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. The Prostate 2002;50:222-35.
3. Dorkin TJ, Neal DE. Basic science aspects of prostate cancer. Seminars in cancer biology 1997;8:21-7.
4. Mora LB, Buettner R, Ahmad N, Bassel Y, Jove R, Seigne JD. Prostate adenocarcinoma: cellular and molecular abnormalities. Cancer Control 2001;8:551-61.
5. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nature reviews: Cancer 2002;2:584-93.
6. Wetterwald A, Van der Pluijm G, Que I, et al. Optical imaging of cancer metastasis to bone marrow. Am J Pathol 2002;160:1143-53.
7. Deguchi T, Yang M, Kawada Y. Micrometastasis of prostate cancer to lymph nodes: detection by means of reverse transcription-polymerase chain reaction. J Natl Cancer Inst 1997;89:1471-2.
8. Zeidman I, McCutcheon M, Coman DR. Factors affecting the number of tumor metastasis, experiments with a transplantable mouse tumor. Cancer Res 1950;10:357-61.
9. Rose WC. Evaluation of Madison 109 lung carcinoma as a model for screening antitumor drugs. Cancer Treat Rev 1981;65:299-312.
10. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 1988;48:6863-71.
11. Rubio N, Martinez-Villacampa M, Blanco J. Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker. Lab Invest 1998;78:1315-25.
12. Lin WC, Pretlow TP, Pretlow TG, Culp LA. Bacterial Lac Z gene as a highly sensitive marker to detect micrometastasis formation during tumor progression. Cancer Res 1990;50:2808-17.
13. Chishima T, Miyagi Y, Wang X, et al. Metastatic patterns of lung cancer visualized live and in process by green fluorescent protein expression. Clin Exp Metastasis 1997;15:547-52.
14. Yang M, Jiang P, Sun F-X, et al. A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res 1999;59:781-6.
15. Zhang L, Hellström KE, Chen L. Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin Exp Metastasis 1994;12:87-92.
16. Yang M, Baranov E, Moossa AR, Penman S, Hoffman RM. Visualizing gene expression by whole-body fluorescence imaging. Proc Natl Acad Sci U S A 2000;97:12278-82.
17. Sweeney TJ, Mailänder V, Tucker AA, et al. Visualizing the kinetics of tumor cell clearance in living animals. Proc Natl Acad Sci U S A 1999;96:12044-9.
18. El hilali N, Rubio N, Martinez-Villacampa M, Blanco J. Combined noninvasive imaging and luminometric quantification of luciferase labeled human prostate tumors and metastases. Lab Invest 2002;82:1563-71.
19. Campbell AS, Sala-Newby, G. Bioluminescent and chemiluminescent indicators for molecular signalling and function in living cells. In: Fluorescent and luminescent probes for biological activity. New York: Academic Press; 1996. p. 58-82.
20. Rubio N, Martinez-Villacampa M, El hilali N, Blanco J. Metastatic Burden in nude mice organs measured using prostate tumor PC-3 cells expressing the luciferase gene as a quantifiable tumor cell marker. The Prostate 2000;44:133-43.
21. Euhus DM, Hudd C, LaRegina MC, Johnson FE. Tumor measurement in the nude mouse. J Surg Oncol 1986;31:229-37.
22. Yang M, Li L, Jiang P, Moossa AR, Penam S, Hoffman RM. Dualcolor fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci USA 2003; 100:14259-62.
23. Cunha GR, Matrisian LM. It's not my fault, blame it on my microenvironment. Differentiation 2002;70:469-72.
24. Seljelid R, Jozefowski S, Sveinbjörnsson B. Tumor stroma. Anticancer Res 1999;19:4809-22.
25. Rowinsky EK, Donehower RC. Drug therapy: paclitaxel (Taxol) review. N Engl J Med 1995;332:1004-14.
26. Vaishampayan U, Fontana J, Du W, Hussain M. An active regimen of weekly paclitaxel and estramutine in metastatic androgen-independent prostate cancer. Urology 2002;60:1050-4.
27. Stephenson RA, Diney CPN, Gohji K, Ordonez NG, Killion JJ, Fidler IJ. Metastatic model of human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992;84:951-7.